Global Trends in Lipoprotein(a) and High-Sensitivity C-Reactive Protein Testing in Patients with Established Atherosclerotic Cardiovascular Disease | Synapse
February 28, 2026Open Access
Global Trends in Lipoprotein(a) and High-Sensitivity C-Reactive Protein Testing in Patients with Established Atherosclerotic Cardiovascular Disease
Key Points
To examine global trends in lipoprotein(a) and high-sensitivity C-reactive protein testing in patients with atherosclerotic cardiovascular disease.
Analysis of testing trends for lipoprotein(a) and C-reactive protein.
Focus on patients with established atherosclerotic cardiovascular disease.
Comparison of testing across different regions and demographics.
Increased testing rates for lipoprotein(a) observed globally.
High-sensitivity C-reactive protein testing shows variable trends across regions.
Trends indicate a growing recognition of these biomarkers in cardiovascular risk assessment.